Mode
Text Size
Log in / Sign up

Robotic cholecystectomy shows fewer complications and shorter hospital stay for gallbladder cancerRobotic Surgery for Gallbladder Cancer Shows Benefits

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider robotic cholecystectomy as a safe alternative to open surgery for gallbladder cancer, but await randomized trials for definitive guidance.

A meta-analysis of five propensity-score-matched studies compared robotic radical cholecystectomy (RRC) with open radical cholecystectomy (ORC) in patients with gallbladder cancer. The analysis included a total of 629 participants, with 202 undergoing RRC and 427 undergoing ORC.

The authors found that RRC was associated with fewer major complications, lower visual analog scale pain scores, less intraoperative blood loss, and shorter hospital stays compared to ORC. There were no significant differences between the groups in mortality, overall morbidity, operative time, number of harvested lymph nodes, R0 resection rate, blood transfusion, readmission, or survival outcomes including 3-year and 5-year overall and disease-free survival.

The authors note that the analysis is limited by the inclusion of only five propensity-score-matched studies and the lack of randomized controlled trials. Confidence intervals for the effect estimates were not fully reported in the abstract, and the observational nature of the included studies means the findings represent associations rather than causation.

Clinically, this meta-analysis suggests that robotic surgery may offer perioperative benefits without compromising oncologic outcomes in gallbladder cancer. However, clinicians should interpret these results cautiously, as higher-quality randomized evidence is needed to confirm the findings and guide practice.

A meta-analysis of five studies involving 629 patients compared robotic radical cholecystectomy (RRC) to open radical cholecystectomy (ORC) for gallbladder cancer. The analysis found that patients who had robotic surgery experienced fewer major complications, less pain (lower VAS scores), less blood loss during surgery, and shorter hospital stays. However, there were no significant differences in mortality, overall complications, surgery time, number of lymph nodes removed, or rates of complete tumor removal (R0 resection).

Survival outcomes were also similar between the two groups. The 3-year and 5-year survival rates, as well as disease-free survival, showed no significant differences. This suggests that robotic surgery does not compromise long-term outcomes compared to open surgery.

It is important to note that these findings come from observational studies, not randomized controlled trials. The studies used propensity-score matching to reduce bias, but the results should be interpreted with caution. The authors call for further randomized trials to confirm these benefits.

Overall, robotic surgery appears to be a safe and effective option for gallbladder cancer, offering potential short-term advantages without sacrificing long-term survival.

What this means for you:
Robotic surgery for gallbladder cancer may reduce complications and hospital stay while maintaining similar survival to open surgery.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundThe use of robotic surgery for gallbladder cancer (GBC) has increased in recent years. However, concerns remain regarding the safety and oncologic efficacy of robotic-assisted surgery for GBC.ObjectiveThis systematic review and meta-analysis aimed to compare the safety and efficacy of robotic radical cholecystectomy (RRC) versus open radical cholecystectomy (ORC).MethodsThe PubMed, Cochrane Library, Scopus, EMBASE, and Web of Science databases were searched to identify available research published up to January 13, 2026. Odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated.ResultsA total of 5 propensity-score-matched studies including 629 participants (RRC group: 202 patients; ORC group: 427 patients) were included. Compared with the ORC group, the RRC group had fewer major complications (OR, 0.42), lower VAS scores (MD, −0.53), less intraoperative blood loss (MD, −114.77 mL), and shorter hospital stay (MD, −2.92 days). No significant differences were observed between the groups in mortality (OR, 1.38), overall morbidity (OR, 0.75), operative time (MD, 2.11 min), number of harvested lymph nodes (MD, 0.13), R0 resection (OR, 1.14), blood transfusion (OR, 0.25), readmission (OR, 1.22), 3-year survival rate (OR, 1.01), 5-year survival rate (OR, 1.04), 3-year disease-free survival (OR, 1.02), or 5-year disease-free survival (OR, 1.13).ConclusionsThis meta-analysis suggests that robotic surgery is a safe and effective approach for the surgical management of GBC, with postoperative and survival outcomes comparable to those of open surgery. Additionally, robotic surgery may be associated with shorter hospital stay, fewer major complications, reduced intraoperative blood loss, and lower VAS scores compared with open surgery. Further randomized controlled trials are warranted to confirm the potential advantages of RRC over ORC.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261364335.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.